Investigation of the Efficacy and Safety of JTT-751 in Non-dialysis CKD Patients (Double-blind Comparative Study)

Trial Profile

Investigation of the Efficacy and Safety of JTT-751 in Non-dialysis CKD Patients (Double-blind Comparative Study)

Completed
Phase of Trial: Phase III

Latest Information Update: 24 May 2016

At a glance

  • Drugs Ferric citrate (Primary)
  • Indications Hyperphosphataemia
  • Focus Therapeutic Use
  • Sponsors Japan Tobacco
  • Most Recent Events

    • 18 Nov 2015 Primary endpoint of change in serum phosphate from baseline to the end of treatment has been met, according to results published in the Clinical Journal of The American Society of Neprology: CJASN.
    • 18 Nov 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top